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MEDICINE AND PHISIOLOGY
APPLICATION OF OSTEOTROPIC THERAPY DEPENDING 
ON THE ACTIVITY OF THE OSTEOPROPIC PROCESS 
IN ALVEOLAR BONE
Inna Gorb-Gavrylchenko,
Candidate of Medicine Sciences, Associate Professor,
SI “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine” 
Annotation. The bone tissue metabolism, in women after ovariectomy, was study in this 
work to evaluate the effectiveness of a differentiated approach in the appointment of osteotropic 
therapy in the treatment of generalized periodontitis in this contingent of patients. The research 
results confirm the necessity to distinguish three forms of activity of the osteoporotic process in 
the alveolar bone with the purpose inventions of individual treatment tactics for each group of 
patients.
Key words: generalized periodontitis, ovariectomy, osteotropic therapy, biochemical markers.
Osteoporotic changes caused by the interruption or subsidence in the function 
of the gonads in women are observed in various parts of the skeleton, including the 
periodontal bone tissue, which, apparently, is one of the reasons for the sharp increase in 
the periodontal disease incidence in this patient population [1,2,3].  
Osteoporotic changes in the skeleton effect dental plates as well aggravating 
destruction of both alveolar bone and parodontium conjunctive tissue [4,5]. Basing upon 
the accumulated data, American Dental Association considers osteoporosis as a risk 
factor for the development of inflammatory diseases of parodontium [6].    
A study by M. Tezal and J. Wactawski-Wende (2000), which included 70 women aged 
51 to 78 years, revealed a correlation between the amount of sex hormones and the mineral 
density of the alveolar bone. The authors conclude, that postmenopausal osteoporosis is 
a prime risk factor for periodontal disease, and the alveolar resorption and the number of 
teeth lost by postmenopausal women depends on the degree of osteopenia [7].
In terms of the current stage of clinical stomatology development, it is not difficult 
to make a diagnosis of parodontium diseases [8]. At the same time, determining the 
nature of clinical progression, prognosis of the disease development, interconnection 
with general state of a patient, ratio between changes in parodontal complex and skeletal 
system in general require further analysis [9].
Оur own observations is demonstrate the high prevalence of periodontal pathology 
in women with total ovariectomy and confirmed all of the above. Besides, the severity of 
periodontitis correlated with the duration of surgical menopause [10]
The basic tasks in the modern parodontology are to find and substantiate the 
application of the means of pathogenetic therapy as well as to differentiate the prescription 
of treatment agents according to the clinical findings of parodontitis, stomatological 
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status, and general patient status. Dependence of the parodontium issues status upon the 
hormonal status of patients with surgical menopause determines the necessity to include 
specific osteoporosis medications into the traditional scheme of generalized parodontitis 
treatment [11].  
The interest in the drugs administration with antiresorptive and osteotropic effects 
in medicine has been increase in over recent years [12,13]. However, clear indications 
for the use of such drugs have not yet been developed, depending on the state of bone 
remodeling processes in a particular patient. Undoubtedly, only a comprehensive study 
of the content of the main biochemical markers not only can determine the intensity 
of bone metabolism [14], but also which process prevails (resorption or inhibition of 
bone formation). Only having such information, can it be possible to develop individual 
tactics for the treatment of generalized periodontitis in women with “turned off” ovarian 
function.
Objective is estimate efficiency of the treatment of generalized periodontitis in 
women after ovariectomy by the state of bone remodeling processes.
Objects and methods of the study. A clinical, radiological and laboratory 
examination was carried out in 60 women, aged 30 to 50 years, who had underwented 
ovariectomy and suffering from generalized periodontitis. Patients were divided into two 
groups: the first (I) group (28 women) included patients with low-activity local areas 
of osteoporosis in the alveolar bone, the second (II) (32 women) - with middling active 
and active local areas of osteoporosis. The control group consisted of 20 healthy women 
without clinical and biochemical signs of an inflammatory and destructive process in 
paradontium. 
Control examinations, necessary corrective treatment, preventive services were 
carried out by active consultation call patients with generalized periodontitis, on the 
background of surgical menopause, at  3 and 5 years after end of course of treatment. 
Clinical examination of patients was performed according to the generally accepted 
scheme which included analysis patient's complaints, medical history, simple 
examination, results of objective data. The parameters of periodontal indices and tests 
took into account for an objective assessment of the condition of periodontal tissues: data 
of the periodontal index A.L. Russel (1956), digital Schiller-Pisarev test, PMA index, 
gum bleeding index H.R. Muhlemain (1971). Periodontal bone tissue was evaluated by 
orthopantomograms using the index of the osteoporotic process in the alveolar process 
(I. Mashchenko, A. Samoilenko) [15]. 
The level of the main calcitropic hormones: parathyroid hormone and calcitonin; 
blood ionized calcium levels and biochemical markers (osteocalcin in blood and urinary 
oxyproline excretion) of bone metabolism were examine for determine the state of 
processes of bone tissue metabolism. The enzyme multiplied immunoassay, with the aid 
the kit from CIS bio international (France), was used for assess the parathyroid hormone 
and calcitonin. Bone tissue resorption marker – oxyproline, was determined by the 
reaction with paradimethylaminobenzaldehyde according to the method of A. A. Krell 
and Furtseva L.N. [16]. Osteocalcin was determined by the radioimmunoassay with the 
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aid the kit from CIS bio international (France). The level of ionized calcium in blood 
serum was determined using a «Huma-Laser-2000» biochemistry analyzer (Germany) 
with the aid kits from the Hoospiten Diagnostics company (Switzerland).
Statistic data were processed by means of a computer with the help of Statistica 8.0 
(Stat Soft, Inc.), Biostatistics 4.03 (Mc Graw Hill) statistic programs and Excel 2007 
(Microsoft, Corp.) electronic tables powered by Windows Vista (Microsoft, Corp.). 
Differences between the compared values were determined according to the Student 
criterion and considered to be accurate in terms of critical level of significance of 
differences (p) being less than 0.05. 
Previous researches testify that the use of Calcium-D3 Nycomed is effectually for 
women with low-activity local areas of osteoporosis in the alveolar bone (group I). 
Women with middling active and high active of  osteoporotic process in the alveolar 
bone (group II) be in need of  to use a combination of pharmaceutical drugs with different 
mechanisms of action, such a combination was composed of Calcium-D3 Nycomed, 
Fosamax and hormone replacement therapy drug Proginova [14].
Clinical, radiological and laboratory examinations were performed before treatment, 
3 and 5 years after the completed course of treatment.
Control examinations, necessary corrective treatment, preventive services were 
carried out by active consultation call patients with generalized periodontitis, on the 
background of surgical menopause, at  3 and 5 years after end of course of treatment.     
Research results and their discussion. During the analysis of the results of 
treatment of generalized periodontitis in women, after total ovariectomy, one year after 
the treatment, disease recurrence, were not determined. In the first group of the study 3 
years after the treatment, positive clinical results were observed in 26 (92.9%) women, 
in the second group - in 28 (87.5%), the disease recurrence were observed in 2 (7.1%) 
and 4 ( 12.5%), respectively.
The index of the osteoporotic process is the most informative indicator of the 
effectiveness of the treatment (Fig. 1). The index of the osteoporotic process is the most 
informative indicator of the effectiveness of the performed treatment. So, in patients of 
group II, at 3 years after end of course of treatment, the measure of this index decreased 
to 7.44±0.17 score, against 13.64±0.18 score before treatment, and at 5 years after end of 
course of treatment to 5.11±0.17 score. In women of the first studies group, with clinical 
and radiological stabilization at 3 years after end of course of treatment, the measure of 
this index was 4.41±0.50 score, at 5 years after end of course of treatment - 4.55±0.70 
score (p <0.05). 
The decrease in the activity index of osteoporosis in the alveolar process in all 
study groups, in the long term after the performed treatment, indicates an increase in the 
mineralization of the alveolar bone and durable clinical and radiological stabilization (Fig.1).
While analyzing the indicators of markers of bone metabolism, was identified, that 
the levels of osteocalcin at 3 and 5 years after end of course of treatment in patients 
group II, with middling and high activity of osteoporosis in the inter alveolar septum, did 
not essentially varied (osteocalcin: at 3 years - 20.0 ± 1.4 IU g/l, at 5 years - 19.1 ± 1.1 
Modern Science — Moderní věda 2020 № 3
97
IU g/l), and be in accord with the control group (table .1). In women of the first studies 
group, in the long term after the treatment, there was observable some decrease in the 
level of osteocalcin to 17.1 ± 1.2 IU g/l at 3 years and to 16.7 ± 0.8 IU g/l at 5 years after 
end of course of treatment (table .1).
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Fig. 1. Dynamics of osteoporosis index (in points)
On the same lines, the study of oxyproline markers indicated accurate about decrease 
the boneʼs resorption markers in this group of patients after tested treatment complexes. 
The oxyproline indicator in women group II decreased by 3 times at 3 years after end of 
course of treatment, as compared with the initial (0.70 ± 0.02 mmol/l versus 2.40 ± 0.04 
mmol/l, р<0.05). The oxyproline indicator in women group I decreased by 1.5 times and 
was 0.61 ± 0.03 mmol/l versus 0.83 ± 0.03 mmol/l, р<0.05 if untreated (table .1).
Table 1
Changes in measures of markers of bone metabolism (M ± m)
Groups Treatment duration
Measurements
Osteocalcin
(IU g/l)
Oxyproline / Cr
(mmol/l)
Group І 
(n = 28)
Pretherapy 20,1±1,1** 0,83±0,03**
At 1 years 19,9±1,2*** 0,53±0,04***
At 3 years 17,1±0,8*** 0,61±0,03***
Group ІІ 
(n = 32)
Pretherapy 14,1±0,9** 2,40±0,04**
At 1 years 20,0±1,4*** 0,55±0,01***
At 3 years 19,1±1,1*** 0,70±0,02***
20,9±1,4 0,54±0,02 20,9±1,4 0,54±0,02
Notes:
        1. *р<0,05 - accuracy in relation to measurements pretherapy;
        2. ** р<0,05 - accuracy in relation to persons of the control group;
        3. n - the number of patients in the group.
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The results of study secretion parameters of the main calcium-regulating hormones 
show the normalization of mineral metabolism. Analysis of the parameters of calcium-
tropic hormones showed that results of patients group II were the most approximate 
to the control group. The level of calcitonin in these patients was 17.8 ± 0.9 pg / ml, 
parathyroid hormone 17.4 ± 1.3 pg / ml (table .1).
Was present some decrease in measures calcitonin and an increase in measures 
parathyroid hormone in women group I (table 2). 
Table 2
Changes in measures of calciumtropic hormones and ionized calcium (M ± m)
Groups Treatment duration
Measurements
Calcitonin
pg / ml
Parathyroid 
hormone 
pg / ml
Ionized calcium 
mmol/l
Group І 
(n = 28)
Pretherapy 14,1±0,4** 24,9±1,4** 1,04±0,01**
At 1 years 17,9±0,4*** 17,5±1,6*** 1,24±0,05***
At 3 years 16,1±0,8*** 18,9±1,2*** 1,22±0,05***
Group ІІ 
(n = 32)
Pretherapy 8,1±0,4** 39,2±0,7** 0,85±0,02**
At 1 years 18,2±0,3*** 16,7±1,5*** 1,26 ±0,03***
At 3 years 17,8±0,9*** 17,1±1,3*** 1,24 ±0,04***
Control group (n=20) 18,2±0,7 16,9±0,9 1,25 ±0,04
Notes:
        1. *р<0,05 - accuracy in relation to measurements pretherapy;
        2. ** р<0,05 - accuracy in relation to persons of the control group;
        3. n - the number of patients in the group.
Performed complex treatment had favorably an effect on levels of ionized calcium 
(table. 2).
Conclusions. The biochemical studies of calcium homeostasis, hormonal status, 
and markers of bone metabolism confirm the need for women, after total ovariectomy 
and suffering from generalized periodontitis, to give prominence three forms of activity 
of the osteoporotic process in the alveolar bone, with the purpose of to develop for 
each group of patients individual treatment tactics. The research results indicate the 
advisability of a differentiated approach in the institution of osteotropic therapy.
For women after total ovariectomy, with low-activity local areas of osteoporosis in 
the alveolar bones, a calcium preparation (Calcium D3 Nycomed) is sufficient. In the 
presence the middling active and active local areas of osteoporosis in the alveolar bone 
tissue, it is more appropriate to prescribe calcium preparations and antiresorptive agents 
in combination with drugs that normalize the endocrine profile. 
In view of the established features, has been developed and tested the complex 
pathogenetically substantiated method for the treatment of generalized periodontitis in 
this group of patients. It provides, along with basic therapy, prescribing Calcium - D3 
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Nycomed, Fosamax and Proginova. Calcium-D3 Nycomed (a third-generation calcium 
preparation) increases the level of calcium in the blood, resulting in inhibition of the 
secretion of parathyroid hormone synthesis, which in turn leads to a decrease in bone 
resorption. Fosamax has a powerful anti-resistance ability, by reducing the activity of 
osteoclasts, stimulates the processes of reossification and mineralization of the bone 
tissue of the alveolar process, contributes to the clinical stabilization of the pathological 
process in periodontal tissues. Hormone replacement therapy has a protective effect 
on bone tissue, reducing bone resorption, by normalizing the endocrine profile (in 
particular, hormones that regulate calcium-phosphorus metabolism). These facts 
indicate how clinically important it is when prescribing complex methods of treating 
generalized periodontitis in women after ovariectomy to analyze those changes that are 
caused by endocrine pathology and have pathogenetic significance in the development 
of osteoporotic changes in the alveolar bones. The correct choice of adequate treatment 
methods for generalized periodontitis without taking them into account is impossible.
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